Results 131 to 140 of about 131,368 (156)

Potent Melanin Production Enhancement of Human Tyrosinase Gene by Tat and an Entrapment in Elastic Cationic Niosomes: Potential Application in Vitiligo Gene Therapy

Chemical Biology & Drug Design, 2012
Potent melanin production enhancement of human tyrosinase plasmid (pAH7/Tyr, P) in mouse melanoma cells (B16F10) by Tat peptide (T) and an entrapment in elastic cationic niosomes (E) was described. The E composed of Tween 61/cholesterol/dodecyl dimethyl ammonium bromide at 1:1:0.5 molar ratio was prepared by freeze‐dried emptying liposomes method.
Jiradej, Manosroi, Narinthorn, Khositsuntiwong, Friedrich, Götz, Rolf G, Werner, Worapaka, Manosroi, Aranya, Manosroi   +5 more
openaire   +2 more sources

Tat-regulated production of multimerized TAR RNA inhibits HIV-1 gene expression.

The New biologist, 1991
Transcriptional activation of gene expression directed by the long terminal repeat (LTR) of the human immunodeficiency virus type 1 (HIV-1) requires both the Tat activation response element (TAR) and the Tat protein. Mutants lacking a functional tat gene are not able to replicate.
J, Lisziewicz, J, Rappaport, R, Dhar
openaire   +1 more source

Production and purification TAT-Cre: A cell penetrating fusion protein that recombines floxed genes

2009
Cre recombinase is an enzyme that recognizes loxP (Locus of Crossover in P1; 34 base pairs length) sites inserted into a target gene that flank a specific sequence of DNA. This enzyme first cuts a DNA sequence that is encompassed by flanking loxP (floxed) sites and then rejoins the two ends of DNA resulting in recombination of a gene.
openaire   +1 more source

Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individuals.

Journal of acquired immune deficiency syndromes, 1991
The relation between antibody-response profiles to Escherichia coli-produced HIV-1 nef, rev, tat, and protease proteins and the risk of developing AIDS was studied using stored serum samples taken sequentially from a cohort of 195 initially symptom-free men who were seropositive for antibodies to HIV-1 structural proteins and 72 men who seroconverted ...
Reiss, P., de Wolf, F., Kuiken, C. L., de Ronde, A., Dekker, J., Boucher, C. A., Debouck, C., Lange, J. M., Goudsmit, J.   +8 more
openaire   +2 more sources

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce, Lorenzo Cohen, Karen M Mustian   +2 more
exaly  

MONO- AND DI- DNA-ENZYME AGAINST THE REGULATORY GENE TAT OF HIV-1 ALSO INTERFERES WITH THE PRODUCTION OF VIRUS PARTICLES

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 1999
Hoshang Unwalla, Ritu Goila, Akhil C. Banerjea   +2 more
openaire   +1 more source

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg, William L Hwang, Anirban Maitra   +2 more
exaly  

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein, Rene-Jean Bensadoun, Andrei Barasch   +2 more
exaly  

The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment

Ca-A Cancer Journal for Clinicians, 2018
Pricivel M Carrera, Hagop M Kantarjian, Victoria S Blinder   +2 more
exaly